Fisher & Paykel Healthcare Corporation Limited
FSPKF
$20.70
$2.3412.75%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.58% | 11.37% | 19.61% | 15.80% | 2.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.58% | 11.37% | 19.61% | 15.80% | 2.59% |
| Cost of Revenue | -5.67% | -0.49% | 15.35% | 11.68% | 1.41% |
| Gross Profit | 13.25% | 19.46% | 22.39% | 18.50% | 3.42% |
| SG&A Expenses | -0.92% | 4.52% | 11.27% | 7.73% | 8.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.30% | 3.06% | 13.79% | 10.17% | 4.85% |
| Operating Income | 34.54% | 41.93% | 44.44% | 39.84% | -4.94% |
| Income Before Tax | 189.34% | 205.22% | 48.35% | 43.64% | -56.71% |
| Income Tax Expenses | -3.20% | 2.11% | 61.45% | 56.32% | 14.51% |
| Earnings from Continuing Operations | 720.56% | 765.59% | 44.29% | 39.70% | -84.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 720.56% | 765.59% | 44.29% | 39.70% | -84.06% |
| EBIT | 34.54% | 41.93% | 44.44% | 39.84% | -4.94% |
| EBITDA | 30.44% | 37.60% | 40.43% | 35.97% | -0.12% |
| EPS Basic | 715.79% | 761.07% | 43.29% | 38.70% | -84.17% |
| Normalized Basic EPS | 41.80% | 49.60% | 47.16% | 42.52% | -12.67% |
| EPS Diluted | 726.92% | 774.22% | 42.73% | 38.31% | -84.41% |
| Normalized Diluted EPS | 41.65% | 49.52% | 47.03% | 42.37% | -12.76% |
| Average Basic Shares Outstanding | 0.47% | 0.47% | 0.75% | 0.75% | 0.79% |
| Average Diluted Shares Outstanding | 0.54% | 0.54% | 0.83% | 0.83% | 0.87% |
| Dividend Per Share | -5.42% | -0.14% | 4.04% | 0.54% | -0.55% |
| Payout Ratio | -0.79% | -0.79% | -0.25% | -0.25% | 3.96% |